Have your own idea? Try our Stock Screener
Russian (MOEX) Biotech Industry Analysis
UpdatedFeb 05, 2024
DataAggregated Company Financials
Companies1
- 7Dn/a
- 3Mn/a
- 1Yn/a
- YTDn/a
Industry Valuation and Performance
Has the Russian Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 15 Feb 2024 | ₽4.3b | ₽1.1b | ₽16.9m | 253.1x | 253.1x | 3.7x |
| Sat, 13 Jan 2024 | ₽4.3b | ₽1.1b | ₽16.9m | 253.1x | 253.1x | 3.7x |
| Mon, 11 Dec 2023 | ₽4.3b | ₽1.1b | ₽16.9m | 253.1x | 253.1x | 3.7x |
| Wed, 08 Nov 2023 | ₽4.3b | ₽1.1b | ₽16.9m | 253.1x | 253.1x | 3.7x |
| Fri, 06 Oct 2023 | ₽4.3b | ₽1.1b | ₽16.9m | 253.1x | 253.1x | 3.7x |
| Sun, 03 Sep 2023 | ₽4.3b | ₽1.1b | ₽16.9m | 253.1x | 253.1x | 3.7x |
| Tue, 01 Aug 2023 | ₽4.3b | ₽1.1b | ₽16.9m | 253.1x | 253.1x | 3.7x |
| Thu, 29 Jun 2023 | ₽4.3b | ₽1.1b | ₽16.9m | 253.1x | 253.1x | 3.7x |
| Sat, 27 May 2023 | ₽4.3b | ₽1.1b | ₽16.9m | 253.1x | 253.1x | 3.7x |
| Mon, 24 Apr 2023 | ₽4.3b | ₽1.1b | ₽16.9m | 253.1x | 253.1x | 3.7x |
| Wed, 22 Mar 2023 | ₽4.3b | ₽1.1b | ₽16.9m | 253.1x | 253.1x | 3.7x |
| Fri, 17 Feb 2023 | ₽4.3b | ₽1.1b | ₽16.9m | 253.1x | 253.1x | 3.7x |
| Sun, 15 Jan 2023 | ₽4.3b | ₽1.1b | ₽16.9m | 253.1x | 253.1x | 3.7x |
| Tue, 13 Dec 2022 | ₽4.3b | ₽1.1b | ₽16.9m | 253.1x | 253.1x | 3.7x |
| Thu, 10 Nov 2022 | ₽4.3b | ₽1.1b | ₽16.9m | 253.1x | 253.1x | 3.7x |
| Sat, 08 Oct 2022 | ₽4.3b | ₽1.1b | ₽16.9m | 253.1x | 253.1x | 3.7x |
| Mon, 05 Sep 2022 | ₽4.3b | ₽1.1b | ₽16.9m | 253.1x | 253.1x | 3.7x |
| Wed, 03 Aug 2022 | ₽4.3b | ₽1.2b | ₽11.6m | 368.6x | 368.5x | 3.6x |
| Fri, 01 Jul 2022 | ₽4.2b | ₽1.2b | ₽11.6m | 357.9x | 357.9x | 3.5x |
| Sun, 29 May 2022 | ₽5.0b | ₽1.2b | ₽11.6m | 432.7x | 432.7x | 4.3x |
Price to Earnings Ratio
432.7x
Current Industry PE
- There is only one company in the Russian Biotechnology industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
- The earnings for companies in the Biotechnology industry have declined 5.6% per year over the last three years.
- Meanwhile revenues have remained mostly flat.
- This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Comparison
How does Russian Biotech compare with similar industries?
| RU Market | 0% | 0 |
| Healthcare | 0% | 0 |
| Biotech | 0% | 0 |
| Biotech | 0% | 0 |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| No data available | |||||